Leading state institution Guangzhou Laboratory, which specializes in respiratory disease research, is working on a ground-breaking vaccination that can perhaps stop the spread of tuberculosis (TB). Renowned respiratory specialist Zhong Nanshan said in a video presentation on Thursday during a tuberculosis awareness campaign in Guangzhou, Guangdong province. The event took place in expectation of the 30th World TB Day, marked on March 24.
Eliminating TB calls for a team effort including early diagnosis, fast treatment, stigma reduction, and medical technological innovation, Zhong underlined. He exhorted medical experts to keep refining diagnosis techniques and treatment strategies as well as to raise public knowledge. Head of Guangzhou Laboratory and academician at the Chinese Academy of Engineering, Zhong has been instrumental in expanding study on respiratory diseases. The highest civilian decoration bestowed to him by China is the Medal of the Republic.
The most recent advancements in short-term therapy and vaccination research in Guangdong province have set the stage for eradicating TB, Zhong said. With almost 741,000 of the over 10 million new TB cases reported globally every year registered in China, the World Health Organisation’s (WHO) 2024 report highlights the major public health issue the nation deals with.
Still, attempts to stop TB in Guangdong have show encouraging results. Thanks to aggressive preventive and control programs, the province has seen a 51 percent drop in recorded TB infections since late 2012. Having a population of more than 127 million, Guangdong has effectively diagnosed and treated around 720,000 TB patients since 2012, keeping a low death rate and a treatment success rate of 90 percent. TB incidence in the province reduced by 8.9% in 2023 alone as compared to last year.
The provincial capital, Guangzhou, has become a model city for tuberculosis prevention and control in China. With a startling 94.89% treatment success rate and a mortality rate of just 0.31 per 100,000 cases last year, the city noted an incidence rate of 33.82 per 100,000 people. These numbers underline Guangzhou’s successful TB control policies.
Guangzhou Chest Hospital has created China’s most thorough TB subspecialty treatment system to handle difficult cases including neurological, bone, and intestinal tuberculosis, therefore addressing continuing issues. Vice-president of the hospital Hu Jinxing claims the institution provides a focused, simplified method of patient treatment. Those diagnosed with extrapulmonary TB have immediate access to specialist departments, therefore guaranteeing barrier-free treatment all through their medical course.
Apart from developments in medicine, Guangzhou has launched extensive screening campaigns aiming at high-risk groups such elderly people, university students, and diabetic sufferers. The city has started pilot initiatives meant to develop “tuberculosis-free zones,” a closed-loop system for TB diagnosis, treatment, and long-term management.
China is making great progress in the fight against tuberculosis by means of ongoing investment in research and healthcare facilities. Offering optimism for a time when the illness is no more a major public health concern, the possible breakthrough vaccination being researched in Guangzhou could signal a turning point in worldwide attempts at TB eradication.Top Respiratory Expert Says China’s Breakthrough TB Vaccine Could Stopper Transmission
Leading state institution Guangzhou Laboratory, which specializes in respiratory disease research, is working on a ground-breaking vaccination that can perhaps stop the spread of tuberculosis (TB). Renowned respiratory specialist Zhong Nanshan said in a video presentation on Thursday during a tuberculosis awareness campaign in Guangzhou, Guangdong province. The event took place in expectation of the 30th World TB Day, marked on March 24.
Eliminating TB calls for a team effort including early diagnosis, fast treatment, stigma reduction, and medical technological innovation, Zhong underlined. He exhorted medical experts to keep refining diagnosis techniques and treatment strategies as well as to raise public knowledge. Head of Guangzhou Laboratory and academician at the Chinese Academy of Engineering, Zhong has been instrumental in expanding study on respiratory diseases. The highest civilian decoration bestowed to him by China is the Medal of the Republic.
The most recent advancements in short-term therapy and vaccination research in Guangdong province have set the stage for eradicating TB, Zhong said. With almost 741,000 of the over 10 million new TB cases reported globally every year registered in China, the World Health Organisation’s (WHO) 2024 report highlights the major public health issue the nation deals with.
Still, attempts to stop TB in Guangdong have show encouraging results. Thanks to aggressive preventive and control programs, the province has seen a 51 percent drop in recorded TB infections since late 2012. Having a population of more than 127 million, Guangdong has effectively diagnosed and treated around 720,000 TB patients since 2012, keeping a low death rate and a treatment success rate of 90 percent. TB incidence in the province reduced by 8.9% in 2023 alone as compared to last year.
The provincial capital, Guangzhou, has become a model city for tuberculosis prevention and control in China. With a startling 94.89% treatment success rate and a mortality rate of just 0.31 per 100,000 cases last year, the city noted an incidence rate of 33.82 per 100,000 people. These numbers underline Guangzhou’s successful TB control policies.
Guangzhou Chest Hospital has created China’s most thorough TB subspecialty treatment system to handle difficult cases including neurological, bone, and intestinal tuberculosis, therefore addressing continuing issues. Vice-president of the hospital Hu Jinxing claims the institution provides a focused, simplified method of patient treatment. Those diagnosed with extrapulmonary TB have immediate access to specialist departments, therefore guaranteeing barrier-free treatment all through their medical course.
Apart from developments in medicine, Guangzhou has launched extensive screening campaigns aiming at high-risk groups such elderly people, university students, and diabetic sufferers. The city has started pilot initiatives meant to develop “tuberculosis-free zones,” a closed-loop system for TB diagnosis, treatment, and long-term management.
China is making great progress in the fight against tuberculosis by means of ongoing investment in research and healthcare facilities. Offering optimism for a time when the illness is no more a major public health concern, the possible breakthrough vaccination being researched in Guangzhou could signal a turning point in worldwide attempts at TB eradication.
